Abstract
WNK1 (with-no-lysine[K]-1) is a protein kinase of which mutations cause a familial hypertension and hyperkalemia syndrome known as pseudohypoaldosteronism type 2 (PHA2). Kidney-specific (KS) WNK1 is an alternatively spliced form of WNK1 kinase missing most of the kinase domain. KS-WNK1 downregulates the Na+-Cl- cotransporter NCC by antagonizing the effect of full-length WNK1 when expressed in Xenopus oocytes. The physiological role of KS-WNK1 in the regulation of NCC and potentially other Na+ transporters in vivo is unknown. Here, we report that mice overexpressing KS-WNK1 in the kidney exhibited renal Na+ wasting, elevated plasma levels of angiotensin II and aldosterone yet lower blood pressure relative to wild-type littermates. Immunofluorescent staining revealed reduced surface expression of total and phosphorylated NCC and the Na+-K+-2Cl- cotransporter NKCC2 in the distal convoluted tubule and the thick ascending limb of Henle's loop, respectively. Conversely, mice with targeted deletion of exon 4A (the first exon for KS-WNK1) exhibited Na+ retention, elevated blood pressure on a high-Na+ diet and increased surface expression of total and phosphorylated NCC and NKCC2 in respective nephron segments. Thus, KS-WNK1 is a negative regulator of NCC and NKCC2 in vivo and plays an important role in the control of Na+ homeostasis and blood pressure. These results have important implications to the pathogenesis of PHA2 with WNK1 mutations.
Original language | English (US) |
---|---|
Article number | ddq525 |
Pages (from-to) | 855-866 |
Number of pages | 12 |
Journal | Human molecular genetics |
Volume | 20 |
Issue number | 5 |
DOIs | |
State | Published - Mar 2011 |
ASJC Scopus subject areas
- Molecular Biology
- Genetics
- Genetics(clinical)